Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Stan, if you read the board regularly other than just post your own biased views you would realise that most posters on here are aware of the company mentioned in that bbc article. The interesting thing is that a link exists between them and Novacyt, we have employees of Nova including GM himself at one point liking posts from Optigene. We are confident Nova are involved with the LAMP test and know that we are bringing out new innovative products in the near future. Thank you for your concerns, however your constant undermining of people’s investments is boring. Move on and focus on your own investment strategy.
EBITDA profit for the forst 6 months is £41m. Estimate second half to be higher. Say its £60m. Thats £100m profit with 71m shares in issue how much do you envisage they can afford to pay as a divi. It wouldnt be very enticing if its below 50p and it wouldnt be affordable if its greater. I personally dont see it happening but then i cant see the order book and potential contracts. It could happen as the chairman hinted to it in his statement in the accounts. It would draw in institutions. We need to know how much revenue they forecast for 2021 and we need big contracts for this!
Good post Brent. Point 1 can not be over emphasised enough. I have been in a number of shares over the years and impatience got the better of me. They went on to double or triple in some cases. I am not making that mistake again. I have done my homework and am confident the company will deliver. Nova will be mid-cap next year no doubt. Growth is growth, spotting it early is rare.
This is just the beginning imo. Great to see the signs. Join the dots... mobile testing at airports with a new saliva based test. Collinson/swissport contract..if there was ever a share to hold now it is most definetley this one!
Simple posted it. Would like to see the email exchange but doubt will get to see it. I recall a few months ago someone enquiring with the directors about them buying shares for shareholder confidence and i cant remember the response but it was very positive.
Exactly. June revenue and forward sold orders are two seperate things. They may have a bunch of debtors with generous payment terms considering the pandemic. We wont know any of this until sighted on the SOFP. I am not concerned with current sales but with what is to come. It will only get better and thats why i am invested. They are front runners, working with AZ, existing relationship and contract with PHE. What more signs do people need. Buy when others doubt and are fearful.
Remember also it is in the BOD’s very best interest the share price gets to or exceeds the year high by September as there bonuses and rewards package will be based on it. If i was the CEO and i had some nuggets in the pipeline i would do what serves my best interests!
A good point of reference for valuation based on covid is the Quiagen situation with Thermo. A major shareholder in Quiagen stated that the value of the company had increased by $2bn based on its revenue and forward book from testing kits for covid. I dont know how many we have sold in comparison to them but that should put some perspective on it.
Key to this company growing over the next 12-18 months is contracts for new innovative products in testing. Yesterday told us the money has been spent and new products are coming. We know our governement are about to spend a whole lot of money on testing and others will follow suit. We need Graham and the team to deliver on this front. If they are successful then the mcap will follow suit. A LOT hinges on this next few weeks.
Well summed up Bluelight. Essentially the company is bearing the costs now (first half of the year) to benefit from the fruits later. The second half of the year will see significant cash growth imo. From that point and going into 2021 the company can then consider acqusitions and divi’s etc. The strategy they are on is the right one and the market will realise this over the coming weeks/months
Out in force. De-ramping and scaremongering. Like i said yesterday. I was fireworks with the half yearly update as most of it was priced in. People assuming we made £22m in June have not got a clue. That figure includes the spend for R&D and that is what is most interesting as the market does not know/expect what is to come. I am looking forward to the next month or so. It is no coincidence the company mentioning multiple new products and innovations at the same time the government are putting out a £5bn tender to laboratory based diagnostic companies. The new saliva test and multiplex winter test will win a hige chunk of that. Patience will pay off, it almost always does!
Yep - why would they like a tweet about saliva testing. The rns mentioned investment in R&D for new products and this is what is coming. In my view this is the biggy, this is the one which will get a big chunk of that £5bn and will be used in mobile locations across the UK and worldwide soon. The market pretty much priced us in for the first 6 months. I wasnt expecting a big rise unless the figures were astronomical. It is all about what the market is not expecting which will cause the SP to rocket. Next few weeks will be big here!
https://mobile.twitter.com/profit_is_king/status/1282586793955778560
Its coming!! This with mobile testing at airports and the UK £5bn tender. Second half of the year sales will increase is an understatement by the company imo they will be significantly higher!
A lot to come and the Mcap will catch up with fundamentals. Imo it will happen the day you least expect so i dont even bother trying to trade here and there incase i miss it. Sit on your hands and it will come when it comes.
Tender deadline is 20 July. So i imagine announcements will be made a few weeks after that. Early August will be instrumental here. Momentum will pick up and buyers will flood in as we draw nearer the end of the month.